Dirk Roggenbuck

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 13

Top Topics

Systemic Sclerosis

Ankylosing Spondylitis

Top Venues

Auto- immunity highlights

Turkish journal of biology = Turk biyoloji dergisi

This page only lists publications with an associated author ORCID identifier.

Publications

Bilge Debelec Butuner, Nurşah Ertunç Hasbal, Elif Işel, Dirk Roggenbuck, Kemal Sami Korkmaz
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer. Turkish journal of biology = Turk biyoloji dergisi 47 (5) (2023)
Bilge Debelec Butuner, Nurşah Ertunç Hasbal, Elif Işel, Dirk Roggenbuck, Kemal Sami Korkmaz
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer. Turkish journal of biology = Turk biyoloji dergisi 47 (5) (2023)
Steffi Lopens, Ewa Wunsch, Małgorzata Milkiewicz, Nadja Röber, Grit Zarske, Abdullah Nasser, Karsten Conrad, Martin W Laaß, Stefan Rödiger, Marcin Krawczyk, Dirk Roggenbuck, Piotr Milkiewicz
PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis. Diagnostics (Basel, Switzerland) 12 (11) (2022)
Romano Weiss, Sanaz Karimijafarbigloo, Dirk Roggenbuck, Stefan Rödiger
Applications of Neural Networks in Biomedical Data Analysis. Biomedicines 10 (7) (2022)
Jonas Schmidt, Sandro Berghaus, Frithjof Blessing, Holger Herbeck, Josef Blessing, Peter Schierack, Stefan Rödiger, Dirk Roggenbuck, Folker Wenzel
Genotyping of familial Mediterranean fever gene (MEFV)-Single nucleotide polymorphism-Comparison of Nanopore with conventional Sanger sequencing. PloS one 17 (3) (2022)
Victoria Liedtke, Christian Schröder, Dirk Roggenbuck, Romano Weiss, Ralf Stohwasser, Peter Schierack, Stefan Rödiger, Lysann Schenk
LEDGF/p75 Is Required for an Efficient DNA Damage Response. International journal of molecular sciences 22 (11) (2021)
Annika Reddig, Linda Voss, Karina Guttek, Dirk Roggenbuck, Eugen Feist, Dirk Reinhold
Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA Damage. Journal of clinical medicine 10 (7) (2021)
Jonas Schmidt, Sandro Berghaus, Frithjof Blessing, Folker Wenzel, Holger Herbeck, Josef Blessing, Peter Schierack, Stefan Rödiger, Dirk Roggenbuck
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics. GeroScience 43 (5) (2021)
Marc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, Tomas Malinauskas, Thomas Buettner, Laura Rose, Peter Schierack, Martin F Sprinzl, Clemens J Sommer, Karl J Lackner, Adriano Aguzzi, Dirk Roggenbuck, Katrin B M Frauenknecht
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS pathogens 17 (12) (2021)
Xavier Bossuyt, Jan Damoiseaux, Niels Rasmussen, Pieter van Paassen, Bernard Hellmich, Bo Baslund, Daniel Blockmans, Pieter Vermeersch, Marcos Lopez-Hoyos, Martine Vercammen, Elisa Barret, Friederike Hammar, Ulrich Leinfelder, Michael Mahler, Nina Olschowka, Dirk Roggenbuck, Wolfgang Schlumberger, Roger Walker, Johan Rönnelid, Jan-Willem Cohen Tervaert, Elena Csernok, Walter Fierz, null null
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper. Clinical chemistry and laboratory medicine 59 (2) (2020)
Tamas Tornai, David Tornai, Nora Sipeki, Istvan Tornai, Rayan Alsulaimani, Kai Fechner, Dirk Roggenbuck, Gary L Norman, Gabor Veres, Gabriella Par, Alajos Par, Ferenc Szalay, Peter Laszlo Lakatos, Peter Antal-Szalmas, Mária Papp
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. Scientific reports 8 (1) (2018)
Cecilia Nalli, Valentina Somma, Laura Andreoli, Thomas Büttner, Peter Schierack, Michael Mahler, Dirk Roggenbuck, Angela Tincani
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto- immunity highlights 9 (1) (2018)
Kai Grossmann, Nadja Röber, Rico Hiemann, Stefan Rödiger, Peter Schierack, Dirk Reinhold, Martin W Laass, Karsten Conrad, Dirk Roggenbuck
Simultaneous detection of celiac disease-specific IgA antibodies and total IgA. Auto- immunity highlights 7 (1) (2016)
Aleksey Maslyanskiy, Natalya Lazareva, Polina Olinek, Peter Schierack, Christian Hentschel, Juliane Cuccato, Dimitrios P Bogdanos, Sergey V Lapin, Dirk Roggenbuck
Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis. Journal of immunology research 2014 (2014)